skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ramucirumabQuestion & answer

ramucirumab · Medicine question

Can ramucirumab increase the risk of gastrointestinal perforation?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, ramucirumab may increase the risk of gastrointestinal perforation, and cases have been reported in patients receiving it.

Sources for this answer

Cyramza 10 mg/ml concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 18Document updated 7 April 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about ramucirumab

Can ramucirumab cause severe high blood pressure?What symptoms can occur during an infusion-related reaction to ramucirumab?For which adults with gastric cancer is ramucirumab (Cyramza) used with paclitaxel?For which adults with non-small cell lung cancer is ramucirumab (Cyramza) used with erlotinib?Has the safety and efficacy of ramucirumab (Cyramza) been established in children and adolescents under 18?How much sodium and polysorbate 80 does a 10 ml vial of ramucirumab (Cyramza) contain?

ramucirumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the ramucirumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX